VYNE - Vyne reports positive data from Phase 1b study for vitiligo drug
2024-01-10 18:39:48 ET
More on VYNE Therapeutics
- Vyne Therapeutics jumps 52% on positive data from trials and $88M financing
- Seeking Alpha’s Quant Rating on VYNE Therapeutics
- Historical earnings data for VYNE Therapeutics
- Financial information for VYNE Therapeutics
For further details see:
Vyne reports positive data from Phase 1b study for vitiligo drug